Flavocoxid, a Nutraceutical Approach to Blunt Inflammatory Conditions

Effects of flavocoxid, a dual inhibitor of COX and 5-lipoxygenase enzymes, on benign prostatic hyperplasia

(2012) D Altavilla et al.   BRITISH JOURNAL OF PHARMACOLOGY

Chronic pancreatitis

(2011) Joan M Braganza et al.   LANCET

Flavocoxid Inhibits Phospholipase A2, Peroxidase Moieties of the Cyclooxygenases (COX), and 5-Lipoxygenase, Modifies COX-2 Gene Expression, and Acts as an Antioxidant

(2011) Bruce P. Burnett et al.   MEDIATORS OF INFLAMMATION

Flavocoxid, an anti-inflammatory agent of botanical origin, does not affect coagulation or interact with anticoagulation therapies

(2010) Lakshmi Pillai et al.   ADVANCES IN THERAPY

Efficacy and safety of flavocoxid, a novel therapeutic, compared with naproxen: a randomized multicenter controlled trial in subjects with osteoarthritis of the knee

(2010) Robert M. Levy et al.   ADVANCES IN THERAPY

Efficacy and safety of flavocoxid compared with naproxen in subjects with osteoarthritis of the knee— a subset analysis

(2010) Robert Levy et al.   ADVANCES IN THERAPY

Flavocoxid, a dual inhibitor of cyclooxygenase-2 and 5-lipoxygenase, reduces pancreatic damage in an experimental model of acute pancreatitis

(2010) F Polito et al.   BRITISH JOURNAL OF PHARMACOLOGY

GOAL: multicenter, open-label, post-marketing study of flavocoxid, a novel dual pathway inhibitor anti-inflammatory agent of botanical origin

(2010) Lakshmi Pillai et al.   CURRENT MEDICAL RESEARCH AND OPINION

Molecular and cellular mechanisms of pancreatic injury

(2010) Edwin C Thrower et al.   CURRENT OPINION IN GASTROENTEROLOGY

90-Day oral toxicity study of UP446, a combination of defined extracts of Scutellaria baicalensis and Acacia catechu, in rats

(2010) Mesfin Yimam et al.   FOOD AND CHEMICAL TOXICOLOGY

Bioactive eicosanoids: Role of prostaglandin F2α and F2-isoprostanes in inflammation and oxidative stress related pathology

(2010) Samar Basu   MOLECULES AND CELLS

Flavocoxid, a dual inhibitor of cyclooxygenase and 5-lipoxygenase, blunts pro-inflammatory phenotype activation in endotoxin-stimulated macrophages

(2009) D Altavilla et al.   BRITISH JOURNAL OF PHARMACOLOGY

Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: A comparison study with methylprednisolone

(2009) Sonia Messina et al.   EXPERIMENTAL NEUROLOGY

Cyclooxygenase-2 Inhibitors, Nonsteroidal Anti-inflammatory Drugs, and Cardiovascular Risk

(2008) Orly Vardeny et al.   CARDIOLOGY CLINICS